@dansfera: The clinical trial landscape is facing a massive standards crisis, but the solution isn’t coming from where you might think. Paradigm Health is proving that third-party platforms are stepping up to bridge the gap in data validation where sponsors previously struggled. While this decentralized approach is a win for proof-of-concept trials, the question remains: can this model scale across the entire industry without a regulatory mandate? It’s a fascinating shift in who actually owns the infrastructure of innovation. #ClinicalTrials #HealthTech #BioTech #ParadigmHealth #PharmaInnovation